Modalis Therapeutics Corporation (TYO:4883)
Japan · Delayed Price · Currency is JPY 31.00
0.00 (0.00%)
Oct 6, 2026, 3:30 PM JST
Modalis Therapeutics Market Cap
Modalis Therapeutics has a market cap or net worth of 3.3 billion as of October 6, 2026. Its market cap has decreased by -45.00% in one year.
Market Cap
3.30B
Enterprise Value
555.39M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
31.00
ChartMarket Cap Chart
Since August 3, 2020, Modalis Therapeutics's market cap has decreased from 60.66B to 3.30B, a decrease of -94.56%. That is a compound annual growth rate of -37.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 3.30B | -29.78% |
| Dec 30, 2025 | 4.70B | -33.61% |
| Dec 30, 2024 | 7.08B | 80.79% |
| Dec 29, 2023 | 3.92B | -59.92% |
| Dec 30, 2022 | 9.77B | -44.97% |
| Dec 30, 2021 | 17.75B | -71.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PRISM BioLab Co.,LTD | 5.40B |
| Noile-Immune Biotech | 5.08B |
| Chordia Therapeutics | 4.79B |
| Ribomic | 4.30B |
| D. Western Therapeutics Institute | 4.26B |
| Kohjin Bio | 4.21B |
| Transgenic Group | 4.06B |
| Kringle Pharma | 4.06B |